Today: 17 May 2026
RTX stock price slips after Iran-strike surge as defense rally cools
3 March 2026
1 min read

RTX stock price slips after Iran-strike surge as defense rally cools

New York, March 3, 2026, 14:47 ET — Regular session

  • RTX dropped roughly 2.7%, slipping from an earlier session high of $216.16.
  • ITA, the aerospace and defense ETF, dropped roughly 2.1%, lagging behind the wider market.
  • Traders are turning their attention to headlines out of the Middle East, with Friday’s U.S. jobs report also looming large.

Shares of RTX Corporation (RTX) slipped 2.7% to $206.36 Tuesday afternoon, retracing after earlier climbing as high as $216.16. The stock had ended Monday at $212.16.

Defense stocks, sensitive to headlines out of the Middle East, saw selling pressure on Tuesday as traders took profits and the market leaned risk-off. “I just don’t think the average market participant is that moved by the conflict until the price of oil gets to $100 a barrel,” said Alex Morris, CEO of F/m Investments. Reuters

RTX straddles the business: Raytheon, its defense arm, produces missiles and air-defense systems, and Pratt & Whitney provides jet engines. According to Reuters, Raytheon’s Tomahawk cruise missiles featured in the U.S. strikes on Iran.

Most defense names traded in the red. Lockheed Martin slid 1.7%, with Northrop Grumman losing 1.1%. General Dynamics edged lower, off just 0.1%. The iShares U.S. Aerospace & Defense ETF slipped 2.1%. The SPDR S&P 500 ETF also finished down 0.9%.

After a strong jump Monday, defense stocks pulled back as the conflict intensified and investors piled into both defense contractors and energy names. RTX tacked on 4.7% during that session, Investopedia said.

RTX gave its latest update to investors back in late January, putting 2025 sales at $88.6 billion and citing a backlog worth $268 billion. Looking out to 2026, the company is guiding for adjusted sales between $92.0 billion and $93.0 billion, with adjusted EPS seen in a $6.60 to $6.80 range. “We enter 2026 with great momentum and are well positioned to deliver our 2026 financial outlook,” Chairman and CEO Chris Calio said. SEC

But RTX isn’t just a missile play. Pratt & Whitney’s ongoing efforts to resolve issues with its geared turbofan (GTF) engines — the same type found on a large chunk of Airbus A320neo-family aircraft — have disrupted parts supply and clogged maintenance shops throughout the sector.

The war premium doesn’t always stick around. Should fighting ease off or new orders not materialize, defense stocks might surrender some of their recent run-up. Contractors, for their part, remain under the gun from Washington to ramp up production and accelerate deliveries.

Traders are eyeing developments out of the Middle East, bracing for oil’s direction, and waiting on Friday’s U.S. February jobs data set for release at 08:30 a.m. ET.

Stock Market Today

  • Heidelberg Materials Share Price Drops Amid Valuation Debate
    May 16, 2026, 10:32 PM EDT. Heidelberg Materials (XTRA:HEI) shares dropped 7% in one day and 8% over the past week, continuing a downtrend with a 24% decline year-to-date. The global building materials firm's recent revenue was €21.55 billion with €1.99 billion net income. Despite the current share price of €169.15, analysts suggest a fair value of €225.74, indicating possible undervaluation. The company's push into sustainable products, including carbon capture and low-carbon concrete, aims to boost margins as markets shift toward greener materials. The valuation narrative highlights growth potential driven by these initiatives amid recent stock weakness.

Latest articles

Joby Aviation Slides Monday With Air-Taxi in Focus

Joby Aviation Slides Monday With Air-Taxi in Focus

17 May 2026
Joby Aviation shares closed Friday at $10.36, down 2.6% for the day and 4.7% for the week. CEO JoeBen Bevirt-linked trusts sold over 421,000 shares under a preset 10b5-1 plan, filings showed. The stock traded between $10.04 and $10.58 during a volatile week. Broader markets and eVTOL sector peers also declined.
ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

17 May 2026
ImmunityBio closed at $7.97 Friday, down 2.2% after announcing exclusive U.S. rights to Japan BCG Laboratory’s Tokyo-172 strain for bladder cancer therapy. The Tokyo strain remains investigational in the U.S. and is not FDA-approved. Nasdaq was closed for the weekend; the next trading session is Monday. ImmunityBio’s Q1 product revenue rose to $44.2 million with $380.9 million in cash and securities.
Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

17 May 2026
Infleqtion Inc. shares fell 10.95% to $12.44 Friday, capping a rough week for quantum tech stocks. The company reported a first-quarter net loss of $30.3 million on $9.5 million in revenue, with 85% from government contracts. Infleqtion launched a new RF sensing platform and raised its 2026 revenue outlook, but warned of continued operating losses.
Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

17 May 2026
Synopsys shares fell 1.49% Friday to $502.42, ending the week down 2.72% amid a broad tech selloff and news that Coatue Management cut its stake by 54%. The Nasdaq Composite dropped 1.54% Friday, while the Philadelphia semiconductor index slid 4%. Synopsys will report fiscal Q2 results after the market closes on May 27. Wells Fargo and Citigroup raised their price targets for the stock earlier in the week.
Silver plunges as Iran war boosts dollar and delays Fed cuts — SLV back in focus
Previous Story

Silver plunges as Iran war boosts dollar and delays Fed cuts — SLV back in focus

Occidental Petroleum stock price whipsaws as oil jumps on Iran conflict; OXY traders eye March 4 deadline
Next Story

Occidental Petroleum stock price whipsaws as oil jumps on Iran conflict; OXY traders eye March 4 deadline

Go toTop